Keisuke Yamamura

Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models

A. Fujioka, F. Nakagawa, H. Okabe, 2014, Oncology reports.

Abstract 1783: Trifluorothymidine incorporation into DNA strongly enforces the potential of TAS-102 and leads to remarkably prolonged survival of cancer patients

A. Fujioka, H. Okabe, Takamasa Suzuki, 2012 .